4-Reviews
Back

FDA remains skeptical about booster shots despite new Pfizer data suggesting efficacy declines

Third doses of Pfizer's vaccine appeared to boost antibody levels between five-fold and 12-fold, particularly among older adults, but FDA officials expressed doubt about the need for boosters.

Powered by WPeMatico

Share
Related Post